SCHEMBL3713838

SCHEMBL3713838

O=C(O)Cc1cc2cc(F)c(F)cc2[nH]c1=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2D O15399 1/20 0.43
GRIN3B O60391 1/20 0.43
GRIN1 Q05586 1/20 0.43
GRIN2A Q12879 1/20 0.43
GRIN2B Q13224 1/20 0.43
GRIN2C Q14957 1/20 0.43
GRIN3A Q8TCU5 1/20 0.43
HSD17B10 Q99714 10/20 0.43
KDM4E B2RXH2 8/20 0.43
ALDH1A1 P00352 5/20 0.43
CYP1A2 P05177 1/20 0.43
TSHR P16473 5/20 0.41
HPGD P15428 5/20 0.41
MAPT P10636 3/20 0.39
TP53 P04637 1/20 0.39
POLB P06746 1/20 0.39
CASP1 P29466 1/20 0.39
CASP7 P55210 1/20 0.39
EIF4A3 P38919 1/20 0.37
MAPK1 P28482 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3711310 0.86 HSD17B10 (0.38) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL4067945 0.82 HSD17B10 (0.61) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL31146173 0.81 DAO (0.58) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL4064969 0.81 HSD17B10 (0.46) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL30434363 0.75 MAPK1 (0.61) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL5678790 0.75 MAPK1 (0.61) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL3713356 0.75 GRIN2D (0.44) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL3710764 0.75 PTGDR2 (0.47) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL8828102 0.75 KDM4E (0.53) HSD17B10KDM4EALDH1A1TSHRHPGD
SCHEMBL31145902 0.74 TSHR (0.44) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4688748-A1 QUINOLINONE AMIDE COMPOUNDS AND USES THEREOF EDGEWISE THERAPEUTICS, INC. (US) 2026-02-11 EP disclosed
US-20260008774-A1 QUINOLINONE AMIDE COMPOUNDS AND USES THEREOF EDGEWISE THERAPEUTICS INC (US) 2026-01-08 US disclosed
US-12448369-B2 Quinolinone amide compounds and uses thereof EDGEWISE THERAPEUTICS, INC. (US) 2025-10-21 US disclosed
US-20250026740-A1 QUINOLINONE AMIDE COMPOUNDS AND USES THEREOF EDGEWISE THERAPEUTICS, INC. 2025-01-23 US disclosed
WO-2024206339-A1 QUINOLINONE AMIDE COMPOUNDS AND USES THEREOF EDGEWISE THERAPEUTICS, INC. (US) 2024-10-03 WO disclosed
EP-2393806-A1 INHIBITORS OF JUN N-TERMINAL KINASE Elan Pharmaceuticals Inc. (US) 2011-12-14 EP disclosed
WO-2010091310-A1 INHIBITORS OF JUN N-TERMINAL KINASE ELAN PHARMACEUTICALS, INC. (US) 2010-08-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12448369-B2 Quinolinone amide compounds and uses thereof TNNI3, TNNT2, COQ8A GRIN2D 2980/4885GRIN3B 3061/4885GRIN1 2678/4885
US-20250026740-A1 QUINOLINONE AMIDE COMPOUNDS AND USES THEREOF TNNI3, TNNT2, COQ8A GRIN2D 2980/4885GRIN3B 3061/4885GRIN1 2678/4885
US-20260008774-A1 QUINOLINONE AMIDE COMPOUNDS AND USES THEREOF TNNT2, TNNI3, TNNC1 GRIN2D 716/4885GRIN3B 1491/4885GRIN1 708/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.